Goldman Sachs’s Intra-Cellular Therapies Inc. ITCI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-1,473,764
| Closed | -$194M | – | 6579 |
|
|
2025
Q1 | $194M | Buy |
1,473,764
+1,097,347
| +292% | +$137M | 0.04% | 521 |
|
|
2024
Q4 | $31.4M | Sell |
376,417
-79,613
| -17% | -$6.54M | 0.01% | 1707 |
|
|
2024
Q3 | $33.4M | Sell |
456,030
-132,151
| -22% | -$9.93M | 0.01% | 1588 |
|
|
2024
Q2 | $40.3M | Sell |
588,181
-178,246
| -23% | -$12.4M | 0.01% | 1323 |
|
|
2024
Q1 | $53M | Buy |
766,427
+187,812
| +32% | +$12.9M | 0.01% | 1130 |
|
|
2023
Q4 | $41.4M | Buy |
578,615
+199,503
| +53% | +$11.5M | 0.01% | 1311 |
|
|
2023
Q3 | $19.7M | Buy |
379,112
+43,690
| +13% | +$2.55M | 0.01% | 1806 |
|
|
2023
Q2 | $21.2M | Sell |
335,422
-119,692
| -26% | -$7.46M | 0.01% | 1793 |
|
|
2023
Q1 | $24.6M | Buy |
455,114
+100,681
| +28% | +$4.87M | 0.01% | 1619 |
|
|
2022
Q4 | $18.8M | Sell |
354,433
-292,813
| -45% | -$14.7M | 0.01% | 2025 |
|
|
2022
Q3 | $30.1M | Buy |
647,246
+17,952
| +3% | +$938K | 0.01% | 1511 |
|
|
2022
Q2 | $35.9M | Buy |
629,294
+150,576
| +31% | +$8.54M | 0.01% | 1379 |
|
|
2022
Q1 | $29.3M | Buy |
478,718
+243,475
| +103% | +$12.6M | 0.01% | 1741 |
|
|
2021
Q4 | $12.3M | Sell |
235,243
-351,743
| -60% | -$14.8M | ﹤0.01% | 2567 |
|
|
2021
Q3 | $21.9M | Sell |
586,986
-147,630
| -20% | -$5.13M | 0.01% | 1984 |
|
|
2021
Q2 | $30M | Sell |
734,616
-82,423
| -10% | -$3.05M | 0.01% | 1697 |
|
|
2021
Q1 | $27.7M | Buy |
817,039
+213,304
| +35% | +$7.4M | 0.01% | 1654 |
|
|
2020
Q4 | $19.2M | Buy |
603,735
+457,919
| +314% | +$12M | 0.01% | 1891 |
|
|
2020
Q3 | $3.74M | Sell |
145,816
-440,513
| -75% | -$10.1M | ﹤0.01% | 3119 |
|
|
2020
Q2 | $15.1M | Buy |
586,329
+136,265
| +30% | +$2.76M | 0.01% | 1913 |
|
|
2020
Q1 | $6.92M | Buy |
450,064
+238,960
| +113% | +$5.19M | ﹤0.01% | 2380 |
|
|
2019
Q4 | $7.24M | Buy |
211,104
+96,305
| +84% | +$1.16M | ﹤0.01% | 2677 |
|
|
2019
Q3 | $857K | Sell |
114,799
-17,431
| -13% | -$167K | ﹤0.01% | 4136 |
|
|
2019
Q2 | $1.72M | Buy |
132,230
+22,442
| +20% | +$288K | ﹤0.01% | 3640 |
|
|
2019
Q1 | $1.34M | Buy |
109,788
+23,859
| +28% | +$305K | ﹤0.01% | 3891 |
|
|
2018
Q4 | $979K | Buy |
85,929
+18,687
| +28% | +$302K | ﹤0.01% | 3982 |
|
|
2018
Q3 | $1.46M | Sell |
67,242
-2,116
| -3% | -$44.2K | ﹤0.01% | 3809 |
|
|
2018
Q2 | $1.23M | Buy |
69,358
+7,407
| +12% | +$150K | ﹤0.01% | 3942 |
|
|
2018
Q1 | $1.3M | Sell |
61,951
-31,098
| -33% | -$606K | ﹤0.01% | 3880 |
|
|
2017
Q4 | $1.35M | Sell |
93,049
-134,575
| -59% | -$2.08M | ﹤0.01% | 4106 |
|
|
2017
Q3 | $3.59M | Sell |
227,624
-353,146
| -61% | -$5.18M | ﹤0.01% | 3464 |
|
|
2017
Q2 | $7.21M | Buy |
580,770
+447,586
| +336% | +$5.19M | ﹤0.01% | 2765 |
|
|
2017
Q1 | $2.16M | Buy |
133,184
+49,884
| +60% | +$722K | ﹤0.01% | 3671 |
|
|
2016
Q4 | $1.26M | Sell |
83,300
-181,060
| -68% | -$2.56M | ﹤0.01% | 4252 |
|
|
2016
Q3 | $4.03M | Buy |
264,360
+174,010
| +193% | +$7.04M | ﹤0.01% | 3229 |
|
|
2016
Q2 | $3.51M | Buy |
90,350
+65,474
| +263% | +$2.35M | ﹤0.01% | 3155 |
|
|
2016
Q1 | $692K | Sell |
24,876
-2,303
| -8% | -$76.8K | ﹤0.01% | 4423 |
|
|
2015
Q4 | $1.46M | Buy |
27,179
+200
| +0.7% | +$10.1K | ﹤0.01% | 3927 |
|
|
2015
Q3 | $1.08M | Sell |
26,979
-24,729
| -48% | -$807K | ﹤0.01% | 4399 |
|
|
2015
Q2 | $1.65M | Buy |
51,708
+37,104
| +254% | +$941K | ﹤0.01% | 4034 |
|
|
2015
Q1 | $349K | Buy |
+14,604
| New | +$327K | ﹤0.01% | 5499 |
|
|
2014
Q4 | – | Sell |
-10,881
| Closed | -$149K | – | 7348 |
|
|
2014
Q3 | $149K | Sell |
10,881
-14,848
| -58% | -$223K | ﹤0.01% | 6374 |
|
|
2014
Q2 | $434K | Buy |
+25,729
| New | +$425K | ﹤0.01% | 5452 |
|
Other funds holding ITCI
KIM
HNB